HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.

AuthorsShih-Ku Lin, Chih-Ken Chen
JournalThe Journal of clinical psychiatry (J Clin Psychiatry) Vol. 67 Issue 8 Pg. 1307 (Aug 2006) ISSN: 0160-6689 [Print] United States
PMID16965214 (Publication Type: Case Reports, Letter)
Chemical References
  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Aripiprazole
  • Risperidone
Topics
  • Adult
  • Antipsychotic Agents (adverse effects, pharmacology, therapeutic use)
  • Aripiprazole
  • Dyslipidemias (chemically induced, drug therapy)
  • Female
  • Humans
  • Hyperprolactinemia (chemically induced, drug therapy)
  • Obesity (chemically induced, drug therapy)
  • Piperazines (pharmacology, therapeutic use)
  • Quinolones (pharmacology, therapeutic use)
  • Risperidone (adverse effects, therapeutic use)
  • Schizophrenia, Paranoid (drug therapy)
  • Treatment Outcome
  • Weight Gain (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: